← Leaderboards
Mark A Exley
Beth Israel Deaconess Medical Center
$2,283,685
Attributed
$2,283,685
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $303.5K · FY2005–13$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$2,283,685 · 4
By mechanism
R21$1,150,229 · 3
R01$1,133,456 · 1
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Margaret J Koziel$5,996,609
- Maria Serena Longhi$3,119,696
- Barbara Wegiel$4,886,655
- Nezam Hassan Afdhal$3,980,011
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoCellsInflammatoryIn VitroChronicPhysiologicalCytokineLiverT-LymphocyteResponseHepatitis C VirusHepatitis CNatural Killer CellsInflammationInfectionImmunityNovel TherapeuticsPathologyAnti-Inflammatory AgentsBloodAnti-InflammatoryDisease ProgressionAcuteHepatocyte
Grant awards (12)
Obesity increased cancer risk by NKT cell depletion (PQ1)$172,456
R21 · FY2013 · CA · contact PI
Obesity increased cancer risk by NKT cell depletion (PQ1)$227,371
R21 · FY2012 · CA · contact PI
Regulation of hepatic NKT cells by CDld+ liver cells$183,549
R21 · FY2011 · CA · contact PI
Regulation of hepatic NKT cells by CDld+ liver cells$226,853
R21 · FY2010 · CA · contact PI
Innate-like hepatic CD1d-reative NKT cells:Liver Disease$197,460
R01 · FY2008 · DK · contact PI
Innate-like hepatic CD1d-reative NKT cells:Liver Disease$201,489
R01 · FY2007 · DK · contact PI
Innate-like hepatic CD1d-reative NKT cells:Liver Disease$102,000
R01 · FY2007 · DK · contact PI
Innate-like hepatic CD1d-reative NKT cells:Liver Disease$207,507
R01 · FY2006 · DK · contact PI
Innate-like hepatic CD1d-reative NKT cells:Liver Disease$212,500
R01 · FY2005 · DK
Innate-like hepatic CD1d-reactive NKT cell:Liver Disease$212,500
R01 · FY2004 · DK
CD1D REACTIVE T CELLS IN BONE MARROW TRANSPLANTATION$170,000
R21 · FY2002 · CA
CD1D REACTIVE T CELLS IN BONE MARROW TRANSPLANTATION$170,000
R21 · FY2001 · CA